Sign in
Active, not recruitingNo phase

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

Key facts

Who runs it
Shengjing Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
2,000 people, planned
Started
1 Jan 2011
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • retrospective observational study
Record updated
11 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography

Who cannot take part

  • missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels
  • pregnancy
  • reception of reperfusion treatment before admission

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This multi-center retrospective study collected clinical, laboratory, and CT pulmonary angiography parameters with acute pulmonary embolism patients from admission to predict adverse outcomes within 30 days after admission into hospital.

Treatments tested

  • retrospective observational study

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
11 March 2026